Cannabis company GW Pharmaceuticals raises $34.5mm in IPO
Executive Summary
British biotechnology company GW Pharmaceuticals, which is developing prescription drugs derived from cannabis, raised gross proceeds of $34.5mm (UK25mm) in an oversubscribed initial public offering of almost 13.7mm ordinary shares on the Alternative Investment Market. It had originally expected to raise UK16mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice